VANGUARD GROUP INC 13D and 13G filings for Revolution Medicines, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:13 pm Purchase | 2023-12-29 | 13G | Revolution Medicines, Inc. RVMD | VANGUARD GROUP INC | 14,634,391 8.930% | 7,072,481 (+93.53%) | Filing |
| 2023-02-09 11:30 am Purchase | 2022-12-30 | 13G | Revolution Medicines, Inc. RVMD | VANGUARD GROUP INC | 7,561,910 8.520% | 1,262,301 (+20.04%) | Filing |
| 2022-02-10 08:32 am Purchase | 2021-12-31 | 13G | Revolution Medicines, Inc. RVMD | VANGUARD GROUP INC | 6,299,609 8.550% | 2,261,789 (+56.02%) | Filing |
| 2021-02-10 11:47 am Purchase | 2020-12-31 | 13G | Revolution Medicines, Inc. RVMD | VANGUARD GROUP INC | 4,037,820 6.080% | 4,037,820 (New Position) | Filing |